Leading the Way in Life Science Technologies

GEN Exclusives

More »

The Lists

Back to Item »

Top 10 M&A Deals of 2016

While 2016 Didn’t Reach the Heights Predicted, the Overall Value of Biopharma M&A Climbed

Forward this item to a colleague:


(Separate multiple addresses by commas)